Saturday, October 3, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 3 '23)

 


    Antiviral Res

  1. MA S, Chen Y, Zhu J, Zong Y, et al
    N70S/Y155H Combined Mutation of Neuraminidase of Avian Influenza H9N2 Virus confers oseltamivir and zanamivir resistance and pathogenicity to Mice.
    Antiviral Res. 2026 Sep 29:106540. doi: 10.1016/j.antiviral.2026.106540.
    PubMed         Abstract available


    J Infect

  2. NAZARETH J, Martin CA, Pan D, Barr IG, et al
    Ethnic differences in inactivated influenza vaccine immunogenicity in UK Healthcare Workers: A two-year prospective longitudinal study.
    J Infect. 2026 Sep 29:106862. doi: 10.1016/j.jinf.2026.106862.
    PubMed         Abstract available

  3. DUAN Q, Jin X, Fu X, Zhu A, et al
    Household transmission dynamics of human respiratory syncytial virus in China: A multicentre epidemiological and molecular study.
    J Infect. 2026;93:106834.
    PubMed         Abstract available

  4. ZHOU S, Liu C, Liu W, Cai K, et al
    Cross-Neutralizing Antibody Responses to Diverse Coronaviruses in the Human Population.
    J Infect. 2026 Aug 11:106827. doi: 10.1016/j.jinf.2026.106827.
    PubMed         Abstract available

  5. LI X, Mercade-Besora N, Lam AS, Barboza C, et al
    Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of SARS-CoV2 infection related hospitalisations and deaths.
    J Infect. 2026 Aug 5:106825. doi: 10.1016/j.jinf.2026.106825.
    PubMed         Abstract available

  6. QUINOT C, Lunt R, Kirsebom F, Andrews N, et al
    Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England.
    J Infect. 2026;93:106819.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  7. KYAW NTT, Foote MMK, Lo Piccolo AJ, Wallach AB, et al
    Unannounced Drills Using Patient Actors to Evaluate Health Care Facility Readiness for Infectious Disease Outbreaks - New Jersey, New York, and U.S. Virgin Islands, January-June 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:581-587.
    PubMed         Abstract available


    Pediatrics

  8. FRINTNER MP, Freed GL, Byrne BJ, Gottschlich EA, et al
    Pediatrician Burnout Over Time: 2021-2025.
    Pediatrics. 2026;158:e2026076643.
    PubMed         Abstract available


    PLoS Biol

  9. DAILEY KE, Wang Y, Teo QW, Wang C, et al
    Epistasis and pleiotropy constrain the evolution of cross-reactive breadth in a broadly neutralizing influenza antibody.
    PLoS Biol. 2026;24:e3004021.
    PubMed         Abstract available


    PLoS Comput Biol

  10. LEMAITRE J, Lessler J
    Generative diffusion models for spatiotemporal influenza forecasting.
    PLoS Comput Biol. 2026;22:e1014846.
    PubMed         Abstract available


    PLoS One

  11. LI Q, Bond RM, Nisbet E, Dixon G, et al
    The limited effects of social media use on misperceptions Social media's limited role in misperceptions.
    PLoS One. 2026;21:e0354486.
    PubMed         Abstract available

  12. RICO-BOLIVAR DL, Diaz-Brochero C, Hattemer R, Bejarano-Mora CA, et al
    Causes of hospitalization among people living with HIV in a tertiary-care hospital in Bogota, Colombia, 2018-2024.
    PLoS One. 2026;21:e0357788.
    PubMed         Abstract available

  13. DUCHOWNY K, Wang V, Noppert G, Melendez R, et al
    Essential work, unequal places: Neighborhood characteristics of the essential workforce in the United States during the COVID-19 pandemic.
    PLoS One. 2026;21:e0357792.
    PubMed         Abstract available

  14. DE ANDA-JAUREGUI G, Sifuentes-Osornio J, Angulo-Guerrero O, Diaz-De-Leon-Santiago JL, et al
    Complexity of hospital demand during the COVID-19 pandemic in Mexico City.
    PLoS One. 2026;21:e0358798.
    PubMed         Abstract available

  15. NEVES RKAD, Bastos LS, Maciel Villela DA, Saraceni V, et al
    Rehospitalization due to COVID-19 reinfection in Rio de Janeiro, 2020-2022: Associations with vaccination status, sociodemographic and clinical factors.
    PLoS One. 2026;21:e0332281.
    PubMed         Abstract available

  16. BABAZADEH SHAREH M, Kleiner F, Bohme M, Hagele C, et al
    Automated model discovery based on COVID-19 epidemiological data from Thuringia, Germany.
    PLoS One. 2026;21:e0344409.
    PubMed         Abstract available

  17. ONYANGO EO, Kiplagat J, Gokiert R, Owuor PM, et al
    An intersectionality-based policy analysis of COVID-19 measures and women informal food vendors in Kisumu, Kenya.
    PLoS One. 2026;21:e0359620.
    PubMed         Abstract available

  18. MESQUITA S, Loureiro J, Haupt Vieira C, Perfeito L, et al
    Learning from pandemics: Feature selection and clustering for robust digital disease nowcasting.
    PLoS One. 2026;21:e0358063.
    PubMed         Abstract available

  19. ABI ZEID B, El Khoury T, Abdulrahim S, Ghattas H, et al
    Predicting COVID-19 infection among older Syrian refugees in Lebanon: A multi-wave survey.
    PLoS One. 2026;21:e0359272.
    PubMed         Abstract available

  20. BOZDECH M
    Rising performance-efficiency demands in female junior tennis: A longitudinal analysis of ITF World Tennis Tour Juniors rankings, 2004-2025.
    PLoS One. 2026;21:e0359538.
    PubMed         Abstract available

  21. JOHNSON G, Edwards S, Jarman H, Peel E, et al
    Understanding delivery of bad news in the emergency department: A scoping review.
    PLoS One. 2026;21:e0358343.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. DUDLEY C, Magdaleno R, Harding C, Sharma A, et al
    Mantis: A foundation model for mechanistic disease forecasting.
    Proc Natl Acad Sci U S A. 2026;123:e2602542123.
    PubMed         Abstract available


    Vaccine

  23. NIAN H, Ding T, Lee RL, Gebretsadik T, et al
    COVID-19 vaccine uptake among individuals with Down syndrome in the Unites States.
    Vaccine. 2026;92:129128.
    PubMed         Abstract available

  24. OKHOLM AK, Fougeroux C, Hagen SH, Paludan SR, et al
    Virus-like particle display of the SARS-CoV-2 receptor-binding domain using a modular tag/catcher system enhances immunogenicity of a DNA vaccine in mice.
    Vaccine. 2026;92:129117.
    PubMed         Abstract available

  25. C M, Dymock M, Flanagan KL, Plebanski M, et al
    The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.
    Vaccine. 2026;92:129034.
    PubMed         Abstract available

  26. ONISHI S, Suzuki Y, Sugimoto K, Otsuka A, et al
    Improving intradermal dosing consistency in mice using a hollow microneedle: A model study with a SARS-CoV-2 mRNA vaccine.
    Vaccine. 2026;92:129111.
    PubMed         Abstract available

  27. ALMEIDA MG, Alves de Oliveira BF, de Melo Junior EB, de Araujo Rodrigues AR, et al
    Knowledge as a predictor of parental vaccine hesitancy during children's first year of life.
    Vaccine. 2026;92:129127.
    PubMed         Abstract available

  28. DESAI M, Cardona J, Khetan S, Mehta S, et al
    Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine.
    Vaccine. 2026;92:129068.
    PubMed         Abstract available

  29. BLANCHARD C, Myers J, McNabb AL, Lee YA, et al
    Evaluating access to COVID-19 vaccines for children and adolescents in North Carolina through community pharmacies, 2021-2023.
    Vaccine. 2026;92:129125.
    PubMed         Abstract available

  30. FORR A, Salmon DA, Markalanda SH, Joseph A, et al
    Promoting a personalized vaccine information website through social media and local outreach: a dissemination and implementation study.
    Vaccine. 2026;92:129161.
    PubMed         Abstract available

  31. HYDER S, Melchinger H, Malik F, Kuppalli K, et al
    Trust in government institutions and influenza vaccine acceptance among U.S. adults.
    Vaccine. 2026;93:129212.
    PubMed         Abstract available

  32. TSOU TP, Huang YT, Lin CY, Chu PW, et al
    Influenza vaccine effectiveness against influenza-related medical visits, hospitalization and death among adults aged 65 years and older in Taiwan: interim 2024-2025 season result using standard-dose inactivated influenza vaccine.
    Vaccine. 2026;93:129165.
    PubMed         Abstract available

  33. JAYASHANKAR L, DeGrace M, Treanor J, Swanson NJ, et al
    Protection Before Day One: advancing broadly protective seasonal influenza vaccines with pandemic coverage.
    Vaccine. 2026;93:129188.
    PubMed        

No comments:

Post a Comment

My New Space

Most Popular Posts